RFL Rafael Holdings Inc
Price (delayed)
$1.53
Market cap
$37.59M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.19
Enterprise value
$32.54M
Rafael Holdings is focused on development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd. Through
Highlights
The revenue has soared by 96% from the previous quarter and by 93% YoY
Rafael Holdings's gross profit has soared by 65% from the previous quarter and by 63% YoY
Rafael Holdings's quick ratio has shrunk by 84% YoY and by 57% QoQ
The debt has grown by 40% from the previous quarter
Key stats
What are the main financial stats of RFL
Market
Valuations
Earnings
Shares outstanding
24.57M
Market cap
$37.59M
Enterprise value
$32.54M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.44
Price to sales (P/S)
67.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
60.25
Revenue
$540,000
EBIT
-$31.23M
EBITDA
-$31.05M
Free cash flow
-$55.9M
Per share
Balance sheet
Liquidity
EPS
-$1.19
Free cash flow per share
-$2.35
Book value per share
$3.5
Revenue per share
$0.02
TBVPS
$4.05
Total assets
$101.62M
Total liabilities
$11.06M
Debt
$2.39M
Equity
$86.1M
Working capital
$66.27M
Debt to equity
0.03
Current ratio
9.79
Quick ratio
9.66
Net debt/EBITDA
0.16
Margins
Efficiency
Dividend
EBITDA margin
-5,750.4%
Gross margin
84.3%
Net margin
-5,319.1%
Operating margin
-18,776.5%
Return on assets
-28.6%
Return on equity
-30%
Return on invested capital
-37.8%
Return on capital employed
-33.2%
Return on sales
-5,782.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RFL stock price
How has the Rafael Holdings stock price performed over time
Intraday
-0.65%
1 week
0.66%
1 month
11.68%
1 year
-30.77%
YTD
-16.39%
QTD
6.25%
Financial performance
How have Rafael Holdings's revenue and profit performed over time
Revenue
$540,000
Gross profit
$455,000
Operating income
-$101.39M
Net income
-$28.72M
Gross margin
84.3%
Net margin
-5,319.1%
The revenue has soared by 96% from the previous quarter and by 93% YoY
The net margin has plunged by 89% YoY
Rafael Holdings's gross profit has soared by 65% from the previous quarter and by 63% YoY
Rafael Holdings's gross margin has decreased by 16% QoQ and by 16% YoY
Growth
What is Rafael Holdings's growth rate over time
Valuation
What is Rafael Holdings stock price valuation
P/E
N/A
P/B
0.44
P/S
67.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
60.25
The P/B is 74% lower than the 5-year quarterly average of 1.7 and 12% lower than the last 4 quarters average of 0.5
RFL's equity is down by 16% QoQ and by 13% YoY
The revenue has soared by 96% from the previous quarter and by 93% YoY
The price to sales (P/S) is 59% lower than the 5-year quarterly average of 167.1 and 50% lower than the last 4 quarters average of 136.1
Efficiency
How efficient is Rafael Holdings business performance
The return on sales has dropped by 99% year-on-year
Dividends
What is RFL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RFL.
Financial health
How did Rafael Holdings financials performed over time
The total liabilities has soared by 184% QoQ
RFL's current ratio has dropped by 84% year-on-year and by 57% since the previous quarter
The debt is 97% less than the equity
Rafael Holdings's debt to equity has surged by 50% QoQ
The debt has grown by 40% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.